"The Report US Drug
Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts
(2016-2021) provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
Scope of the Report
The
report entitled US Drug Eluting Sinus Stent (DESS) Market: Size,
Trends & Forecasts (2016-2021), provides analysis of the US DESS
market, with detailed analysis of market size and growth,
penetration, market share and economic impact of the industry. The
analysis includes the market by value (TAM), by volume and by
utilization. The report also provides the analysis of the US sinus
surgery market, including analysis of FESS market and BSD market.
Furthermore,
the report also assesses the key opportunities in the market and
outlines the factors that are and will be driving the growth of the
industry. Growth of the overall US DESS market has also been
forecasted for the years 2016-2021, taking into consideration the
growth pattern of sinus surgery market, the growth drivers and the
current and future trends.
View Report @
http://www.marketresearchreports.biz/analysis/810264
Intersect
is the only company manufacturing drug eluting sinus stents, but the
competitive landscape of the market includes other indirect
competitors, such as Medtronic, Entellus Medical and Acclarent (J&J),
whose company profiling has been done in the report. In this segment
of the report, business overview, financial overview and business
strategies of the companies are provided.
Company Coverage
Intersect
ENT
Medtronic
(Xomed)
Entellus
Medical
Acclarent
(J&J)
Get Sample Copy Of This
Report @
Executive Summary
Sinuses
are the hollow cavities located in the bones of the face and around
the nose.
There
are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid,
each with different features. Under normal conditions, the secretion
(mucous) flow through the nasal passages, but with the onset of
sinusitis, the secretion gets blocked in the sinuses due to
inflammation. Sinusitis disturbs the normal lifestyle of a person and
sometimes become frustrating, as it affects the persons breathing,
sleeping and eating.
Sinusitis
can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis
(RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration
of the episode of sinusitis and its severity. The treatment options
for the sinusitis can be over-the-counter treatment, medical
management and surgery. The OTC treatment includes decongestants,
antihistamines, pain relievers and nasal irrigation. Medical
management includes antibiotics and oral and nasal steroids. The
sinus surgeries are mainly of two types: Functional Endoscopic Sinus
Surgery (FESS) and Balloon Sinus Dilation (BSD).
Intersect,
is the only company that has developed drug releasing bio-absorbable
implants (drug eluting sinus stents- DESS) that enable targeted and
sustained release of therapeutic agents, increasing the effectiveness
of the sinus surgery.
The
US DESS market is expected to increase at a significant growth rate
during the forecasted period (2016-2021). The US DESS market is
supported by various growth drivers, such as limitations of FESS
treatment, benefits of DESS, increasing per capita healthcare
expenditure, cost effectiveness of DESS, etc. Yet, the market faces
certain challenges, such as, reimbursement issues, dependability on
individual physicians experience, limited trials after BSD, etc.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment